Form 4: BioLife Solutions EVP Aby J. Mathew Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Aby J. Mathew, EVP & Chief Scientific Officer of BioLife Solutions Inc., sold 547 shares of common stock on October 30, 2024, to satisfy tax withholding obligations.
Summary
- Aby J. Mathew, the EVP & Chief Scientific Officer of BioLife Solutions Inc. (BLFS), reported a transaction involving the sale of company stock.
- On October 30, 2024, Mathew sold 547 shares of common stock at a price of $23.15 per share.
- The sale was executed under a pre-arranged Rule 10b5-1(c) trading plan adopted on January 3, 2023, to cover tax withholding obligations related to the vesting of restricted stock.
- Following the transaction, Mathew still beneficially owns 317,169 shares of BioLife Solutions Inc.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale of shares under a pre-arranged trading plan to cover tax obligations. It doesn't indicate any particular positive or negative outlook for the company.
Industry Context
This is a routine Form 4 filing, indicating an insider transaction. It's common for executives to sell shares to cover tax obligations related to stock vesting. The existence of a pre-arranged 10b5-1 trading plan suggests the transaction was planned well in advance and not based on any specific non-public information.
Key Dates
| Date | Description |
|---|---|
| 01-03-2023 | Date of adoption of Rule 10b5-1(c) trading plan |
| 10/30/2024 | Date of stock sale transaction |
| 11/01/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.